Premier Alternatives

BioConsortia

Davis, CA · Founded 2014 · Privately Held (backing)

Developer of microbial-based agricultural technologies designed to improve crop performance and sustainability. BioConsortia is based in Davis, CA and was founded in 2014. It was valued at $136 million at its later-stage round in Aug 2025, the last priced event on record. It has raised $79 million across 4 recorded rounds; the latest was a $15 million early-stage round in Apr 2023.

PMV mark · valuation
$136.0M
Oct 2026
Priced at
its later-stage round
Aug 2025
Total raised
$79.0M
Last round
Early Stage VC
Apr 2023

BioConsortia key facts

as of Oct 2026
  • Developer of microbial-based agricultural technologies designed to improve crop performance and sustainability.
  • BioConsortia is valued at approximately $136.0M as of Oct 2026, set at its later-stage round, Aug 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $79.0M across 4 recorded rounds; the latest was Early Stage VC ($15.0M) in Apr 2023.
  • Notable investors include Plug and Play Tech Center, Khosla Ventures, Otter Capital, Outset Ventures, Veronica Mason.
  • BioConsortia has filed 5 Form Ds with the SEC since 2016, most recently Apr 2023 ($15.0M sold to 1 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$136.0M

Valued at $136.0M at its later-stage round, Aug 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of BioConsortia with a free account
  • ·Watch BioConsortia: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

BioConsortia funding rounds

4 rounds
Apr 2023Early Stage VC$15.0MSEC filing▮
Mar 2019Early Stage VC$8.0MSEC filing▮
Mar 2018Early Stage VC$10.0MSEC filing▮
Oct 2016Early Stage VC$8.0MSEC filing▮
Full funding history →

BioConsortia valuation

BioConsortia was valued at $136 million at its later-stage round in Aug 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has BioConsortia raised?

BioConsortia has raised $79 million across 4 recorded rounds since 2016. The largest was an $8 million early-stage round in Mar 2019; the most recent was a $15 million early-stage round in Apr 2023.

BioConsortia has filed 5 Form Ds with the SEC since 2016, most recently in Apr 2023 ($15 million sold to 1 investor).

BioConsortia investors

5 investors are on record for BioConsortia, including Plug and Play Tech Center, Khosla Ventures, Otter Capital and Outset Ventures. The early-stage round in Apr 2023 drew 1 investor.

About BioConsortia

Developer of microbial-based agricultural technologies designed to improve crop performance and sustainability. The company utilizes advanced gene discovery, trait mapping, and microbial selection techniques to develop products that enhance nitrogen fixation, bio-pesticide activity, and plant growth under stress, enabling farmers to increase yield, reduce chemical inputs and support soil health through targeted microbial solutions integrated into existing agricultural practices.

Sector
Materials and Resources
HQ
Davis, CA, United States
Founded
2014
Employees
50
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.